Skip to main content
. 2014 Nov 6;9(11):e111168. doi: 10.1371/journal.pone.0111168

Table 2. Oligonucleotides used in this study.

Oligonucleotide Primers Sequence (5′-3′)a
Recombinant expression of GST-Har and variants
HarNterm CGGAATTCATCGAAGGTCGTATGATAGTCACATCA
HarCterm CGCTCGAGCCATATCGGATCAATGTTATATGTCT
Har150_Nterm CCGCGTGGATCCATGATAGTCACATCACTG
Har150_Cterm CGTGGATCCCGGGTTACTGCTTCTTCCTGCATTT
HarC97A SDM GCTTCATTTGCAGAGCAGGCACCGCTGCTTTTCTGTACC
DNA target for EMSA
PGN_0001_240bp_For GGTGTTGATAACTCGGTCGCGCCTT
PGN_0001Rev CTAAAAAAATATCGTTTTGAGAGCAGT
Construction of har mutant
PGN_1502-Fwd ATGTCGCCTTCCGAGGCTAT
ErmF-PGN_1502-Rev GCAATAGCGGAAGCTATCGGTTATCTTTTCGATCCATTCTTGC
PGN_1502-ErmF-Fwd AGAATGGATCGAAAAGATAACCGATAGCTTCCGCTATTGC
Term-ErmF-Rev GTCTTTCGACTGAGCCTTTCGTTTTAGCATCTAATTTAACTTCAATTCC
Term-Prom-region-Fwd GCTCAGTCGAAAGACTGGGCCTTTCGTTTTACGGAGTGAAAAAGGAGCCG
PGN_1504-Prom-region-Rev CAATGTTATATGTCTGTGTTATCTCTCTTTTACATCATATTTTCC
Prom-region-PGN_1504-Fwd AATATGATGTAAAAGAGAGATAACACAGACATATAACATTGATCC
PGN_1504-Rev GCAGATATTTTGTAGCCTCCATC
Construction of har complement
PGN_1502-Fwd ATGTCGCCTTCCGAGGCTAT
CepA-Har-Rev ACTTTCCTTAACTCTTTTGACGTCTTATTTTTTCTTCTTGGGAGCGGCT
Har-CepA-Fwd AGCCGCTCCCAAGAAGAAAAAATAAGACGTCAAAAGAGTTAAGGAAAGT
ErmF-CepA-Rev TGTGTAGGTTCTAATTGAAGGACAGACGTCTCAAGTCACCGATAG
CepA-ErmF-Fwd CTATCGGTGACTTGAGACGTCTGTCCTTCAATTAGAACCTACACA
ErmF-Rev GATACTGCACTATCAACACACTC
qRT-PCR
PGN_0287 RT Fwd CCAGCAGCACTTTCCATACAAA
PGN_0287 RT Rev CCACTGATTACGGCCTCATTT
PGN_0448 RT Fwd AGTAAAGGGGTAGGGCAACG
PGN_0448 RT Rev ATCGGATTCGTGTTCCAAAGC
PGN_1296 RT Fwd CCTGCAAGAGCGTGAAGTTG
PGN_1296 RT Rev GGATCGGAAAGCCGTATAAGC
PGN_1578 RT Fwd TGTTGTGGAAAGGAGTGTGG
PGN_1578 RT Rev AGAAGGAATGAAGTCGGTTGTT
PGN_2083 RT Fwd GCATTCTTTTCTGGCGTAGCA
PGN_2083 RT Rev TTTGCGAAACGGCACTCCCT
a

Underlined sequence of SOE primers indicates the part of the primer that is complementary to the target sequence, with the remainder of the primer providing complementarity with a second PCR product for splicing.